10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

GILEAD SCIENCES, INC.

Ticker: GILD   Fiscal Year: 2013

Consolidated Statements of Income

Period Ending Dec 31, 2013 10-K (Filed: Feb 25, 2014)

(In Thousands)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2013Dec 31, 2012Dec 31, 2011
Revenues [Abstract]
Product sales
$
10,803,695
9,398,3718,102,359
Royalty revenues383,849290,523268,827
Contract and other revenues14,14413,62314,199
Total revenues11,201,6889,702,5178,385,385
 
Costs and Expenses [Abstract]
Cost of goods sold2,858,5022,471,3632,124,410
Research and development expenses2,119,7561,759,9451,229,151
Selling, general and administrative expenses1,699,4311,461,0341,241,983
Total costs and expenses6,677,6895,692,3424,595,544
 
Income from operations4,523,9994,010,1753,789,841
Interest expense(306,894)(360,916)(205,418)
Other income (expense), net(8,886)(37,279)66,581
Income before provision for income taxes4,208,2193,611,9803,651,004
 
Provision for income taxes1,150,9331,038,381861,945
Net income3,057,2862,573,5992,789,059
 
Net loss attributable to noncontrolling interest17,52217,96714,578
Net income attributable to Gilead3,074,8082,591,5662,803,637
 
Net Income Per Share Attributable to Gilead Common Stockholders - Basic (usd per share)2.011.711.81
Shares Used in Per Share Calculation-Basic (shares)1,528,6201,514,6211,549,806
Net Income Per Share Attributable to Gilead Common Stockholders - Diluted (usd per share)1.811.641.77
Shares Used in Per Share Calculation - Diluted (shares)1,694,7471,582,5491,580,236
External Links 
GILEAD SCIENCES, INC. (GILD) Fiscal Year 2013
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip